Kaunitz AM - Search Results

1

The Women's Health Initiative trials of menopausal hormone therapy: lessons learned.

Manson JE, Bassuk SS, Kaunitz AM, Pinkerton JV. Manson JE, et al. Among authors: kaunitz am. Menopause. 2020 Aug;27(8):918-928. doi: 10.1097/GME.0000000000001553. Menopause. 2020. PMID: 32345788 Clinical Trial.

2

The role of androgens in menopausal hormonal replacement.

Kaunitz AM. Kaunitz AM. Endocrinol Metab Clin North Am. 1997 Jun;26(2):391-7. doi: 10.1016/s0889-8529(05)70254-1. Endocrinol Metab Clin North Am. 1997. PMID: 9193891 Review.

3

Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative.

Kaunitz AM; Women's Health Initiative. Kaunitz AM, et al. Medscape Womens Health. 2002 Jul-Aug;7(4):8. Medscape Womens Health. 2002. PMID: 12466740 Free article. No abstract available.

4

The 2012 hormone therapy position statement of: The North American Menopause Society.

North American Menopause Society. North American Menopause Society. Menopause. 2012 Mar;19(3):257-71. doi: 10.1097/gme.0b013e31824b970a. Menopause. 2012. PMID: 22367731 Free PMC article.

5

Study had insufficient power to investigate safety.

Rossouw JE, Manson JE, Kaunitz AM, Stefanick ML. Rossouw JE, et al. Among authors: kaunitz am. BMJ. 2012 Dec 3;345:e8146; author reply e8164. doi: 10.1136/bmj.e8146. BMJ. 2012. PMID: 23208257 No abstract available.

6

Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.

Rossouw JE, Manson JE, Kaunitz AM, Anderson GL. Rossouw JE, et al. Among authors: kaunitz am. Obstet Gynecol. 2013 Jan;121(1):172-6. doi: 10.1097/aog.0b013e31827a08c8. Obstet Gynecol. 2013. PMID: 23262943 Free PMC article.

7

Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study.

Shufelt CL, Merz CN, Prentice RL, Pettinger MB, Rossouw JE, Aroda VR, Kaunitz AM, Lakshminarayan K, Martin LW, Phillips LS, Manson JE. Shufelt CL, et al. Among authors: kaunitz am. Menopause. 2014 Mar;21(3):260-6. doi: 10.1097/GME.0b013e31829a64f9. Menopause. 2014. PMID: 24045672 Free PMC article.

8

Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials.

Simon JA, Portman DJ, Kaunitz AM, Mekonnen H, Kazempour K, Bhaskar S, Lippman J. Simon JA, et al. Among authors: kaunitz am. Menopause. 2013 Oct;20(10):1027-35. doi: 10.1097/GME.0b013e3182a66aa7. Menopause. 2013. PMID: 24045678 Clinical Trial.

9

Extended duration use of menopausal hormone therapy.

Kaunitz AM. Kaunitz AM. Menopause. 2014 Jun;21(6):679-81. doi: 10.1097/GME.0000000000000175. Menopause. 2014. PMID: 24398408

10

Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause.

Portman DJ, Kaunitz AM, Kazempour K, Mekonnen H, Bhaskar S, Lippman J. Portman DJ, et al. Among authors: kaunitz am. Menopause. 2014 Oct;21(10):1082-90. doi: 10.1097/GME.0000000000000210. Menopause. 2014. PMID: 24552977 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters